Font Size: a A A
Keyword [Influenza A]
Result: 181 - 200 | Page: 10 of 10
181. Prokaryotic Expression Of Influenza A (H1N1)2009Virus Hemagglutinin Gene, Preparation Of Antibodies And Application
182. Developing SYBR Green â…  Real-Time PCR Assay For Rapid Detection Of Novel Influenza A H1N1and Seasonal Influenza Virus
183. The Imaging Changes And Clinical Features Of The Confirmed Cases Of New Type Influenza A (H1N1)
184. The Establishment&Improvement Of Influenza A Surveillance System At The Xiamen Port
185. Detecting Transmission And Reassortment Events For Influenza A Viruses With Genotype Profile Method
186. Construction Of Nucleoprotein Fusion Gene And Inhibition Of SiRNA On Expression Of NP Gene In Influenza A Virus
187. Construction Of Influenza A H1N1Variant Virus Vaccine Candidates
188. A Molecular Dynamics Study On The Proton Conduciton Mechanism Of M2Channel From Influenza A Virus
189. Expression Of HA Gene Of H1N1Subtype Influenza A Virus And Its Immunogenicity Analysis
190. The Anti-Viral Activity And Component Analysis Of Alternanthera Phibxeroides Effective Fractions Of Extracts
191. Different Syndrome Types In Patients With Influenza A (h1n1) Change Characteristic Of Mononuclear Cell Immune
192. 2009 Influenza A (h1n1) Virus Was Compared With The Common Seasonal Flu Virus Infection Cell Efficiency
193. Based On The Syndrome Factor Differentiation Of Influenza A (h1n1) Disease Syndrome Study
194. Anti-influenza A Virus Effects Of Cyanovirin-n (CVN) And Its Derivatives In Vitro And In Vivo
195. Analysis Of The Second Structure Of The Influenza A And Implementation Of Web Server Of Multi-scale RNA Comparison Based On RNA Triple Vector Curve Representation
196. The Role Of Host MiRNAs In Inhibiting The Replication Of Influenza A Virus
197. The Development Of A Universal Influenza A Vaccine Based On NP And M1Protein Of Inlfuenza A Virus
198. Microbiota Regulates TLR7Signaling Pathway Against Respiratory Tract Influenza A Virus Infection
199. The Research On Pharmacodynamics And Mechanism Of Anti-influenza A Virus Drugs
200. Construction And Protective Efficacy Of Recombinant Influenza A Virus As A Vector For FLU-RSV Vaccine
  <<First  <Prev  Next>  Last>>  Jump to